TD Cowen Reiterates Buy Rating on VERX

TD Cowen reiterated its buy rating on VERX, setting a price target of $14, as announced on June 29, 2026. This move comes as the stock traded at $11.37 on Monday, reflecting the firm's continued positive outlook on the company's prospects.

Other Institutional Activity in VERX

Several institutional investors have been active in VERX recently. BlackRock, Inc. increased its holdings by 18,194 shares, bringing its total to 5,659,374 shares valued at approximately $67.3 million. UBS Group AG reduced its position by 264,806 shares, now holding 5,464,034 shares worth about $64.97 million. Vanguard Portfolio Management LLC opened a new position with 4,780,681 shares valued at $56.84 million. Morgan Stanley significantly boosted its stake by 3,368,359 shares, now holding 4,293,247 shares valued at $51.05 million. In contrast, Tensile Capital Management LP trimmed its holdings by 21,431 shares, resulting in 3,398,563 shares valued at $40.41 million.

Vertex, Inc. Stock Down 19.9%

Shares of VERX traded near $11.37 on Monday. The stock has experienced some volatility, with peer institutions adjusting their positions significantly. These changes reflect varying levels of confidence among institutional investors, with some expanding their stakes and others reducing their exposure.

Insider Buying and Selling at Vertex, Inc.

In June, several insiders at VERX made notable purchases. On June 10, insiders including Mark Mendola, Amanda Westphal Radcliffe, and Philip Seth Saunders each acquired 15,638 shares. These transactions were not part of a pre-planned trading program, indicating a possible vote of confidence by the company's insiders.

Analysts Set New Price Targets

On June 29, 2026, TD Cowen reiterated its buy rating for VERX, setting a price target of $14. This comes alongside other analyst activities such as Citigroup maintaining a hold rating with a $16 target on May 8, 2026, and Piper Sandler also maintaining a hold rating with a $16 target on May 7, 2026. The consensus among analysts indicates a mixed outlook, with some seeing potential upside and others adopting a more cautious stance.

Bottom Line

TD Cowen's reiteration of a buy rating on VERX, with a $14 price target, highlights continued confidence from at least one analyst firm. Institutional activity shows varied strategies, with some funds increasing their stakes significantly. Insider buying in June could signal optimism about the company's future. As always, it's important for investors to consider these analyses in the context of their own research and investment goals.